GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (OSTO:XINT) » Definitions » Net Interest Income (for Banks)

Xintela AB (OSTO:XINT) Net Interest Income (for Banks)


View and export this data going back to 2016. Start your Free Trial

What is Xintela AB Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Xintela AB (OSTO:XINT) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Medicon Village, Lund, SWE, 22381
Xintela AB is a biomedical company which utilises its proprietary marker technology XINMARK to develop stem cell-based therapies (XSTEM) for osteoarthritis and antibody-based therapies for Glioblastoma and Tripple-negative breast cancer. XSTEM is also evaluated for the treatment of the severe and deadly lung complication ARDS, which may affect covid-19 patients.